THC: Tenet Health Forward Price-to-Revenue Multiple

Tenet (THC) - corporate logo

Tenet Healthcare (THC) has completed its portfolio transformation by expanding its network of profitable outpatient centers. The forward P/S indicator links this strategy to the market valuation, where the 1.90 mark captures this metric. Its status as a leading US hospital operator is protected by regional barriers. The scale of the business allows the behemoth to effectively dictate terms to insurers, maintaining margins through inelastic demand for medical treatment.

tenethealth.com - THC Forward Price to Sales (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Tenet Health (THC)

Summary company analytics:Tenet Healthcare Corporation (THC)
Product sample of Tenet Healthcare

Tenet Healthcare (THC) optimization of operating expenses through the outsourcing of non-core functions directly impacts bottom-line revenue, establishing the basis for calculating market value. This multiple compares current market capitalization with the updated annual sales forecast, reflecting a fundamental business revaluation following each earnings report. Analyzing the forward P/S ratio allows for the timely identification of overvalued shares and prevents the acquisition of the asset at local peaks.

Competing companies

HCA Healthcare - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio FMS (Fresenius Medical Care AG)|SOLV: Forward Price-to-Revenue Multiple|Forward Price to Sales EHC (Encompass)|UHS: Forward P/S Multiple|davita.com - Forward Price to Sales|RDNT (RadNet) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Option Care OPCH|Forward P/S Multiple SGRY|Forward P/S Multiple Premier Health (PINC)|Price-to-Projected Revenue Ratio National Vision Holdings EYE|progyny.com - Price-to-Projected Revenue Ratio|ARDT: Forward Price-to-Revenue Multiple|Select Medical Corporation - Price to Expected Revenue Ratio|ASTH: Forward P/S Multiple|MEDNAX - Forward Price to Sales|USPH (US Physical Therapy) - Forward P/S Multiple|Forward Price-to-Revenue Multiple pennantgroup.com (PNTG)|Forward P/S Multiple ORGO|Forward P/S Multiple Nutex Health Inc (NUTX)|Price-to-Projected Revenue Ratio Auna Health AUNA|Forward Price to Sales SBC|Evolus, Inc. - Forward P/S Multiple|Market Cap to Future Revenue Ratio chs.net|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|MDWD: Price to Expected Revenue Ratio|BTMD (Biote Corp) - Forward P/S Multiple|JYNT: Forward Price to Sales|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple p3hp.org PIII|Gain Therapeutics - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio EUDA (EUDA Health Holdings)|BMGL - Price-to-Projected Revenue Ratio|Forward Price to Sales CLGN (CollPlant Biotechnologies)|CUPR: Forward P/S Multiple|Market Cap to Future Revenue Ratio concordmedical.com (CCM)|AMS (American Shared Hospital Services) - Forward P/S Multiple|Forward P/S Multiple MEDIROM Healthcare Group Inc.|Forward Price-to-Revenue Multiple ALBT (Avalon GloboCare)|Price to Expected Revenue Ratio DHAI|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|NIVF - Forward Price-to-Revenue Multiple|ATI Physical Therapy Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio CareMax Inc.|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Forward Price-to-Revenue Multiple NVOS|SSY (SunLink Health Systems, Inc) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple BACK (IMAC Holdings)